SCRI CCCIT gem GmbH

Salzburg 5020

1 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Sjogrens Syndrome

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling